Sector dividends Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:06:36 18/06/2026 +04			5-day change	1st Jan Change
3.095 ^USD	+3.86%		+4.21%	+12.55%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
PERSPECTIVE THERAPEUTICS, INC.	-.--%	-.--%	-2.69x	1.32x	365.63x	-1.2x	-1.22x	340M
LONZA GROUP AG	1.1%	1.26%	29.79x	3.81x	5.28x	16.37x	22.98x	43.44B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-19.84x	14.48x	293.52x	-18.08x	-17.77x	33.54B
IQVIA HOLDINGS INC.	-.--%	-.--%	20.77x	3.93x	2.44x	10.54x	16.06x	28.48B
BEONE MEDICINES AG	-.--%	-.--%	39.19x	5.85x	3.88x	24.86x	29.42x	29.2B
CELLTRION, INC.	0.42%	0.45%	29.31x	2.17x	7.59x	19.53x	23.31x	25.34B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	26.83x	13.43x	4.29x	19.54x	20.49x	13.05B
EUROFINS SCIENTIFIC SE	1.23%	1.43%	21.72x	2.28x	1.89x	8.33x	13.18x	12.67B
IONIS PHARMACEUTICALS, INC.	-.--%	-.--%	-20.58x	306.9x	13.55x	-20.17x	-19.61x	12.28B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	22.8x	1.12x	1.65x	10.01x	11.46x	10.97B
TEMPUS AI, INC.	-.--%	-.--%	-24.23x	21.62x	5.9x	144.78x	-455.6x	8.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	29.72x	2.66x	2.75x	10.74x	13.03x	8.78B
BIO-TECHNE CORPORATION	0.58%	0.58%	47.17x	3.99x	7.07x	20.04x	21.92x	8.61B
ABIVAX	-.--%	-.--%	-22.96x	39.9x	1745.04x	-24.9x	-25.51x	8.16B
QIAGEN N.V.	-.--%	0.51%	17.45x	1.99x	3.75x	10x	12.8x	7.56B
ALKERMES PLC	-.--%	-.--%	-112.12x	4.03x	4.63x	24.53x	147.2x	7.42B
KYMERA THERAPEUTICS, INC.	-.--%	-.--%	-25.52x	6.57x	71.68x	-16.09x	-15.51x	7.39B
Average	0.2%	0.25%	3.34x	25.65x	149.44x	14.05x	-11.96x	15.65B
Weighted average by Cap.	0.3%	0.35%	11.68x	21.21x	97.00x	12.48x	-0.73x